Bozhou Rongjian Medical Appliance Co., Ltd. appears in FDA premarket notification records as the applicant for cutaneous electrode and nerve stimulator devices. The supplied collection links one 510(k) record, K262664, decided Substantially Equivalent on October 20, 2026, and that single record carries the SESE decision in both the full collection and the smaller record sample. The numbered sources also include earlier Rongjian filings and a later applicant's submission that names a Rongjian electrode as its predicate, which places the company's electrode work in a documented chain of substantial equivalence comparisons. [1][3][5]

The 2026 electrode clearance

K262664 covers the Rongjian Self-adhesive Electrode under product code GXY, regulation number 882.1320, device class 2, with Neurology as the advisory committee. FDA received the submission on July 30, 2026, and decided it on October 20, 2026 as Substantially Equivalent under a Traditional clearance type, with a summary statement and no third-party review. The applicant address in the record is Jianghuai Supply Base, Zhongkai Group, Mengcheng County, Bozhou, 233500, China. [1]

The clearance document describes the Self-adhesive electrode in lead wire type and snap button type as non-sterile flexible structures built from materials commonly used in this application, including electrically conductive carbon film supplied by Hebei Kangshengda Electronic Technology Co., Ltd. Shapes are listed as round and square, and electrical connection is provided through a lead wire. [2]

Earlier electrode filing

An earlier Self-adhesive Electrode submission, K213879, was dated November 24, 2021 and received December 13, 2021, with FDA correspondence dated January 5, 2022. It carries the same regulation number 21 CFR 882.1320, regulation name Cutaneous Electrode, class II and product code GXY, and was routed through a Shanghai-based regulatory consultancy as correspondent. [3]

The comparison table in that review lists design options of round, rectangle, elliptical, calabash, butterfly and palm shapes to customized specification, with lead wire and female socket or snap button and male snap connector, and describes single patient use with multiple application and both OTC and prescription use. [3]

Stimulator filings

Rongjian is also the named applicant on stimulator notifications. K220578 covers the Transcutaneous Electrical Nerve Stimulator, Model RJTENS-1, under regulation 882.5890 and product code GZJ, received February 28, 2022 and decided Substantially Equivalent on May 25, 2022, Traditional review, not third-party reviewed, not a combination product, with Neurology as the review panel. The applicant contact listed is Wu Zhifang. [7]

Two further records name Rongjian stimulator devices: K252688 for the Transcutaneous Electrical Nerve Stimulator (RJTENS-2) under the over-the-counter transcutaneous nerve stimulator classification, and K220153 for the Needle Stimulator, Model RJNS6-1, under the electro-acupuncture stimulator classification. The supplied excerpts identify the applicant and device names without decision details. [6][8]

Role as a named predicate

A later applicant's review document lists the Bozhou Self-Adhesive Electrode, K213879, as the predicate device in a comparison for Tutamen Self Adhesive Electrodes, K252439. That table records the same product code, regulation and class on both sides and states the indications for use as transmitting electrical stimulation current to the patient's skin. This is a documented use of a Rongjian clearance as a comparator, not evidence of any commercial relationship between the two applicants. [5]